Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -32.46% is 103% below its 5-year average of -16.02%, near the low end of its 5-year range (-35.30%–14.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.50% below its 12-month average of -26.28%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -32.46%.
RETURN ON EQUITY (ROE)
-32.46%
RETURN ON EQUITY (ROE) AVG TTM
-26.28%
RETURN ON EQUITY (ROE) AVG 3Y
-26.47%
RETURN ON EQUITY (ROE) AVG 5Y
-16.02%
RETURN ON EQUITY (ROE) AVG 10Y
-10.29%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-23.50%
CURRENT VS 3Y AVG
-22.63%
CURRENT VS 5Y AVG
-102.60%
CURRENT VS 10Y AVG
-215.41%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+22.74%
vs the sector median at left
Xencor, Inc.
Market Cap
$1.79B
Return on Equity (ROE)
-32.46%
TTM Avg
-26.28%
3Y Avg
-26.47%
5Y Avg
-16.02%
Market Cap
$1.79B
Return on Equity (ROE)
N/A
TTM Avg
36.48%
3Y Avg
36.48%
5Y Avg
36.48%
Market Cap
$1.78B
Return on Equity (ROE)
-49.19%
TTM Avg
-59.18%
3Y Avg
-54.84%
5Y Avg
-44.72%
Market Cap
$1.77B
Return on Equity (ROE)
-43.94%
TTM Avg
-43.41%
3Y Avg
-41.23%
5Y Avg
-29.16%
Market Cap
$1.82B
Return on Equity (ROE)
15.62%
TTM Avg
13.87%
3Y Avg
11.38%
5Y Avg
11.40%
Market Cap
$1.81B
Return on Equity (ROE)
N/A
TTM Avg
-157.29%
3Y Avg
-33.70%
5Y Avg
49.06%
Market Cap
$1.77B
Return on Equity (ROE)
-5.30%
TTM Avg
-6.97%
3Y Avg
-4.32%
5Y Avg
-7.48%
Market Cap
$1.82B
Return on Equity (ROE)
-8.95%
TTM Avg
-23.57%
3Y Avg
-73.07%
5Y Avg
-68.36%
Market Cap
$1.74B
Return on Equity (ROE)
N/A
TTM Avg
94.61%
3Y Avg
224.41%
5Y Avg
83.14%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xencor, Inc. (XNCR) | $1.79B | -32.46% | -26.28% | -26.47% | -16.02% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | N/A | 36.48% | 36.48% | 36.48% |
| Absci Corporation (ABSI)vs › | $1.78B | -49.19% | -59.18% | -54.84% | -44.72% |
| Novocure Ltd (NVCR)vs › | $1.77B | -43.94% | -43.41% | -41.23% | -29.16% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 15.62% | 13.87% | 11.38% | 11.40% |
| Novavax, Inc. (NVAX)vs › | $1.81B | N/A | -157.29% | -33.70% | 49.06% |
| Surgery Partners, Inc. (SGRY)vs › | $1.77B | -5.30% | -6.97% | -4.32% | -7.48% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.82B | -8.95% | -23.57% | -73.07% | -68.36% |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | N/A | 94.61% | 224.41% | 83.14% |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 4.88% | 4.47% | 6.79% | 5.89% |
ROE
-32.5%
ROA
-22.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -32.46% |
| 2026-03-31 | -33.44% |
| 2025-12-31 | -14.46% |
| 2025-09-30 | -22.19% |
| 2025-06-30 | -28.86% |
| 2025-03-31 | -33.47% |
| 2024-12-31 | -35.30% |
| 2024-09-30 | -29.27% |
| 2024-06-30 | -33.64% |
| 2024-03-31 | -24.30% |
| 2023-12-31 | -20.12% |
| 2023-09-30 | -17.79% |
| 2023-06-30 | -18.78% |
| 2023-03-31 | -20.41% |
| 2022-12-31 | -7.59% |
| 2022-09-30 | 4.14% |
| 2022-06-30 | 3.03% |
| 2022-03-31 | 14.25% |
| 2021-12-31 | 11.27% |
| 2021-09-30 | -0.67% |
| 2021-06-30 | 3.64% |
| 2021-03-31 | -10.92% |
| 2020-12-31 | -12.11% |
| 2020-09-30 | -14.52% |
| 2020-06-30 | -14.06% |
| 2020-03-31 | -10.33% |
| 2019-12-31 | 4.53% |
| 2019-09-30 | 5.83% |
| 2019-06-30 | 8.05% |
| 2019-03-31 | 6.42% |
| 2018-12-31 | -13.50% |
| 2018-09-30 | -12.03% |
| 2018-06-30 | -15.94% |
| 2018-03-31 | -11.86% |
| 2017-12-31 | -17.35% |
| 2017-09-30 | -15.88% |
| 2017-06-30 | -12.83% |
| 2017-03-31 | 5.07% |
| 2016-12-31 | 7.52% |
| 2016-09-30 | 19.98% |
| 2016-06-30 | 18.45% |
| 2016-03-31 | -11.05% |
| 2015-12-31 | -10.83% |
| 2015-09-30 | -17.41% |
| 2015-06-30 | -14.15% |
| 2015-03-31 | -11.29% |
| 2014-12-31 | -27.70% |
| 2014-09-30 | -31.44% |
| 2014-06-30 | -21.88% |
| 2014-03-31 | -84.77% |
| 2013-12-31 | -81.95% |
